Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Heer

Showing results (21-30 of 28) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 28 results.
Biosensors & Bioelectronics|July 10, 2012
Contemporaneous cell spreading and phagocytosis: magneto-resistive real-time monitoring of membrane competing processesA Shoshi, J Schotter, P Schroeder, et al.
British Journal of Cancer|July 25, 2013
Characterisations of human prostate stem cells reveal deficiency in class I UGT enzymes as a novel mechanism for castration-resistant prostate cancerS C Williamson, R Mitter, A C Hepburn, et al.
Biosensors & Bioelectronics|May 8, 2012
Magnetoresistive-based real-time cell phagocytosis monitoringA Shoshi, J Schotter, P Schroeder, et al.
British Journal of Cancer|May 26, 2011
Thiothymidine combined with UVA as a potential novel therapy for bladder cancerS W Pridgeon, R Heer, G A Taylor, et al.
Oncogene|December 12, 2007
Aberrant expression of extracellular signal-regulated kinase 5 in human prostate cancerS R C McCracken, A Ramsay, R Heer, et al.
Optics Express|July 19, 2020
Ultra-sensitive refractive index sensor using CMOS plasmonic transducers on silicon photonic interferometric platformA Manolis, E Chatzianagnostou, G Dabos, et al.
Oncogene|February 12, 2019
The induction of core pluripotency master regulators in cancers defines poor clinical outcomes and treatment resistanceA C Hepburn, R E Steele, R Veeratterapillay, et al.
Oncogene|May 10, 2019
Correction: The induction of core pluripotency master regulators in cancers defines poor clinical outcomes and treatment resistanceA C Hepburn, R E Steele, R Veeratterapillay, et al.
Pageof 3

Showing results (21-30 of 28) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
Biosensors & Bioelectronics|July 10, 2012
Contemporaneous cell spreading and phagocytosis: magneto-resistive real-time monitoring of membrane competing processesA Shoshi, J Schotter, P Schroeder, et al.
British Journal of Cancer|July 25, 2013
Characterisations of human prostate stem cells reveal deficiency in class I UGT enzymes as a novel mechanism for castration-resistant prostate cancerS C Williamson, R Mitter, A C Hepburn, et al.
Biosensors & Bioelectronics|May 8, 2012
Magnetoresistive-based real-time cell phagocytosis monitoringA Shoshi, J Schotter, P Schroeder, et al.
British Journal of Cancer|May 26, 2011
Thiothymidine combined with UVA as a potential novel therapy for bladder cancerS W Pridgeon, R Heer, G A Taylor, et al.
Oncogene|December 12, 2007
Aberrant expression of extracellular signal-regulated kinase 5 in human prostate cancerS R C McCracken, A Ramsay, R Heer, et al.
Optics Express|July 19, 2020
Ultra-sensitive refractive index sensor using CMOS plasmonic transducers on silicon photonic interferometric platformA Manolis, E Chatzianagnostou, G Dabos, et al.
Oncogene|February 12, 2019
The induction of core pluripotency master regulators in cancers defines poor clinical outcomes and treatment resistanceA C Hepburn, R E Steele, R Veeratterapillay, et al.
Oncogene|May 10, 2019
Correction: The induction of core pluripotency master regulators in cancers defines poor clinical outcomes and treatment resistanceA C Hepburn, R E Steele, R Veeratterapillay, et al.
Pageof 3